Breast cancer is considered the most critical and frequently diagnosed cancer in women worldwide, leading to an increase in cancer-related mortality. Early and accurate detection is crucial as it can help mitigate possible threats while improving survival rates. In terms of prediction, conventional diagnostic methods are often limited by variability, cost, and, most importantly, risk of misdiagnosis. To address these challenges, machine learning (ML) has emerged as a powerful tool for computer-aided diagnosis, with feature selection playing a vital role in improving model performance and interpretability. This research study proposes an integrated framework that incorporates customized Particle Swarm Optimization (PSO) for feature selection. This framework has been evaluated on a comprehensive set of 29 different models, spanning classical classifiers, ensemble techniques, neural networks, probabilistic algorithms, and instance-based algorithms. To ensure interpretability and clinical relevance, the study uses cross-validation in conjunction with explainable AI methods. Experimental evaluation showed that the proposed approach achieved a superior score of 99.1\% across all performance metrics, including accuracy and precision, while effectively reducing dimensionality and providing transparent, model-agnostic explanations. The results highlight the potential of combining swarm intelligence with explainable ML for robust, trustworthy, and clinically meaningful breast cancer diagnosis.

A precise assessment of the risk of breast lesions can greatly lower it and assist physicians in choosing the best course of action. To categorise breast lesions, the majority of current computer-aided systems only use characteristics from mammograms. Although this method is practical, it does not completely utilise clinical reports' valuable information to attain the best results. When compared to utilising mammography alone, will clinical features greatly enhance the categorisation of breast lesions? How may clinical features and mammograms be combined most effectively? In what ways may explainable AI approaches improve the interpretability and reliability of models used to diagnose breast cancer? To answer these basic problems, a comprehensive investigation is desperately needed. In order to integrate mammography and categorical clinical characteristics, this study examines a number of multimodal deep networks grounded on feature concatenation, co-attention, and cross-attention. The model achieved an AUC-ROC of 0.98, accuracy of 0.96, F1-score of 0.94, precision of 0.92, and recall of 0.95 when tested on publicly accessible datasets (TCGA and CBIS-DDSM).

Despite advancements in Computer-Aided Diagnosis (CAD) systems, breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. Recent breakthroughs in Artificial Intelligence (AI) have shown significant promise in development of advanced Deep Learning (DL) architectures for breast cancer diagnosis through mammography. In this context, the paper focuses on the integration of AI within a Human-Centric workflow to enhance breast cancer diagnostics. Key challenges are, however, largely overlooked such as reliance on detailed tumor annotations and susceptibility to missing views, particularly during test time. To address these issues, we propose a hybrid, multi-scale and multi-view Swin Transformer-based framework (MSMV-Swin) that enhances diagnostic robustness and accuracy. The proposed MSMV-Swin framework is designed to work as a decision-support tool, helping radiologists analyze multi-view mammograms more effectively. More specifically, the MSMV-Swin framework leverages the Segment Anything Model (SAM) to isolate the breast lobe, reducing background noise and enabling comprehensive feature extraction. The multi-scale nature of the proposed MSMV-Swin framework accounts for tumor-specific regions as well as the spatial characteristics of tissues surrounding the tumor, capturing both localized and contextual information. The integration of contextual and localized data ensures that MSMV-Swin's outputs align with the way radiologists interpret mammograms, fostering better human-AI interaction and trust. A hybrid fusion structure is then designed to ensure robustness against missing views, a common occurrence in clinical practice when only a single mammogram view is available.

Breast cancer is one of the deadliest cancers causing about massive number of patients to die annually all over the world according to the WHO. It is a kind of cancer that develops when the tissues of the breast grow rapidly and unboundly. This fatality rate can be prevented if the cancer is detected before it gets malignant. Using automation for early-age detection of breast cancer, Artificial Intelligence and Machine Learning technologies can be implemented for the best outcome. In this study, we are using the Breast Cancer Image Classification dataset collected from the Kaggle depository, which comprises 9248 Breast Ultrasound Images and is classified into three categories: Benign, Malignant, and Normal which refers to non-cancerous, cancerous, and normal images.This research introduces three pretrained model featuring custom classifiers that includes ResNet50, MobileNet, and VGG16, along with a custom CNN model utilizing the ReLU activation function.The models ResNet50, MobileNet, VGG16, and a custom CNN recorded accuracies of 98.41%, 97.91%, 98.19%, and 92.94% on the dataset, correspondingly, with ResNet50 achieving the highest accuracy of 98.41%.This model, with its deep and powerful architecture, is particularly successful in detecting aberrant cells as well as cancerous or non-cancerous tumors. These accuracies show that the Machine Learning methods are more compatible for the classification and early detection of breast cancer.

Fox News senior medical analyst Dr. Marc Siegel explains how early detection for breast cancer has improved with the help of artificial intelligence and discusses the factors contributing the rise in stress in America. Although breast cancer deaths have been declining for decades in the U.S., diagnoses have been on the uptick among women 50 and younger. The good news is that since 1989, breast cancer mortality has declined overall by 44% -- but diagnoses of the disease have been rising by 1% each year between 2012 and 2021. The findings were published in CA: A Cancer Journal for Clinicians. Although breast cancer deaths have been declining for decades in the U.S., diagnoses have been on the uptick among women 50 and younger.

As a leading cause of mortality among women globally, the precise and timely diagnosis of breast cancer remains imperative for optimizing patient outcomes. While traditional diagnostic methodologies [2] have historically relied heavily on uni-modal approaches, the evolving landscape of medical data analytics underscores the significance of integrating diverse data sources beyond conventional imaging modalities [3]. Figure 1 illustrates a generic model for breast cancer diagnosis within the Computer-Aided Detection (CAD) framework. As depicted in Figure 2, breast cancer detection can be performed using various data types, employing either unimodal or multimodal approaches. The process initiates with data pre-processing, followed by feature extraction. To enhance the learning of feature representations from image data, segmentation may be conducted prior to feature extraction. Subsequently, the detection model is applied to generate a diagnosis from the processed data. Based on this diagnosis, further analyses are performed, including sub-type classification, grade classification, recurrence and metastasis prediction, as well as the incorporation of crowdsourcing and human-in-the-loop methodologies. These steps culminate in a final decision that informs subsequent treatment and monitoring strategies.

Breast cancer (BC) stands as one of the most common malignancies affecting women worldwide, necessitating advancements in diagnostic methodologies for better clinical outcomes. This article provides a comprehensive exploration of the application of Explainable Artificial Intelligence (XAI) techniques in the detection and diagnosis of breast cancer. As Artificial Intelligence (AI) technologies continue to permeate the healthcare sector, particularly in oncology, the need for transparent and interpretable models becomes imperative to enhance clinical decision-making and patient care. This review discusses the integration of various XAI approaches, such as SHAP, LIME, Grad-CAM, and others, with machine learning and deep learning models utilized in breast cancer detection and classification. By investigating the modalities of breast cancer datasets, including mammograms, ultrasounds and their processing with AI, the paper highlights how XAI can lead to more accurate diagnoses and personalized treatment plans. It also examines the challenges in implementing these techniques and the importance of developing standardized metrics for evaluating XAI's effectiveness in clinical settings. Through detailed analysis and discussion, this article aims to highlight the potential of XAI in bridging the gap between complex AI models and practical healthcare applications, thereby fostering trust and understanding among medical professionals and improving patient outcomes.

Thousands of British women will have their mammograms assessed by an AI'doctor' in a real-time clinical trial aimed at improving early breast cancer detection, Rishi Sunak will announce this week. Speaking ahead of a global summit on artificial intelligence in South Korea, the Prime Minister said the AI technology could help improve aspects of Britain's health service. But they added regulations needed to be brought in to ensure the technology worked for the benefit of mankind and not to its detriment. Alongside his South Korean counterpart, Mr Sunak hailed a collaboration between the NHS and Korean firm Lunit on using AI to improve the speed and accuracy of breast cancer diagnosis as an example of the positives of the new technology. 'AI is changing the world around us.

Breast cancer classification stands as a pivotal pillar in ensuring timely diagnosis and effective treatment. This study with histopathological images underscores the profound significance of harnessing the synergistic capabilities of colour space ensembling and quantum-classical stacking to elevate the precision of breast cancer classification. By delving into the distinct colour spaces of RGB, HSV and CIE L*u*v, the authors initiated a comprehensive investigation guided by advanced methodologies. Employing the DenseNet121 architecture for feature extraction the authors have capitalized on the robustness of Random Forest, SVM, QSVC, and VQC classifiers. This research encompasses a unique feature fusion technique within the colour space ensemble. This approach not only deepens our comprehension of breast cancer classification but also marks a milestone in personalized medical assessment. The amalgamation of quantum and classical classifiers through stacking emerges as a potent catalyst, effectively mitigating the inherent constraints of individual classifiers, paving a robust path towards more dependable and refined breast cancer identification. Through rigorous experimentation and meticulous analysis, fusion of colour spaces like RGB with HSV and RGB with CIE L*u*v, presents an classification accuracy, nearing the value of unity. This underscores the transformative potential of our approach, where the fusion of diverse colour spaces and the synergy of quantum and classical realms converge to establish a new horizon in medical diagnostics. Thus the implications of this research extend across medical disciplines, offering promising avenues for advancing diagnostic accuracy and treatment efficacy.

Adversarial data can lead to malfunction of deep learning applications. It is essential to develop deep learning models that are robust to adversarial data while accurate on standard, clean data. In this study, we proposed a novel adversarially robust feature learning (ARFL) method for a real-world application of breast cancer diagnosis. ARFL facilitates adversarial training using both standard data and adversarial data, where a feature correlation measure is incorporated as an objective function to encourage learning of robust features and restrain spurious features. To show the effects of ARFL in breast cancer diagnosis, we built and evaluated diagnosis models using two independent clinically collected breast imaging datasets, comprising a total of 9,548 mammogram images. We performed extensive experiments showing that our method outperformed several state-of-the-art methods and that our method can enhance safer breast cancer diagnosis against adversarial attacks in clinical settings.